Bilateral intravitreal injections on the rise, study finds

PARIS — A retrospective study carried out in three large centers in France found that one-third of anti-VEGF injections to treat wet age-related macular degeneration and diabetes-related ocular conditions are currently performed bilaterally.“Bilateral injection is not recommended by guidelines, except in specific cases. However, the exponential increase of macular pathologies requiring anti-VEGF treatment and affecting both eyes in most cases may lead to an increasingly frequent adoption of a bilateral protocol,” Typhaine Grenet, MD, said at the meeting of the French Society of Ophthalmology.